Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/1999
06/03/1999WO1999026571A1 Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
06/03/1999WO1999026570A1 Method of cross-linking keratin-based films, sheets, and bulk materials
06/03/1999WO1999026556A1 Biodegradable intra vaginal devices
06/03/1999WO1999018939A9 Methods of treating capsules and dry, powdered pharmaceutical formulations
06/03/1999WO1999013913A3 High viscosity liquid controlled delivery system as a device
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999007418A3 Sterile bioerodible implant device with improved biocompatability and method
06/03/1999CA2312233A1 Preservation of sensitive biological samples by vitrification
06/03/1999CA2310775A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999CA2310725A1 Process for the production of protein fibres and products thereof
06/03/1999CA2310407A1 Formulations comprising dissolved paroxetine
06/02/1999EP0919242A2 Method for administering acylated insulin
06/02/1999EP0919240A1 Anticancer composition
06/02/1999EP0919231A1 Injectable parasiticide composition and process for the preparation
06/02/1999EP0919229A2 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
06/02/1999EP0919228A1 Capsules for oral preparations and capsule preparations for oral administration
06/02/1999EP0919227A1 Effervescent preparation contianing a plant extract
06/02/1999EP0919217A1 Composition based on liquid vesicles and branched and neutralised up to 90% of poly 2 acrylamido - 2 - methylpropane sulfonic acid
06/02/1999EP0918799A1 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
06/02/1999EP0918790A1 Polycationic sterol derivatives as transfection agents
06/02/1999EP0918542A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes
06/02/1999EP0918541A1 Immunstimulating lipid formulation
06/02/1999EP0918539A1 Vaccine for b-cell malignancies
06/02/1999EP0918536A1 Composition comprising insulin and insulin-like growth factor-i (igf-i)
06/02/1999EP0918535A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
06/02/1999EP0918521A1 Formulation for the treatment and/or prophylaxis of dementia
06/02/1999EP0918513A1 Easy to swallow oral medicament composition
06/02/1999EP0918512A1 Homeopathic composition and process for its preparation
06/02/1999EP0918511A2 Lipid-binding proteins and their therapeutic and diagnostic use
06/02/1999EP0918510A1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs
06/02/1999EP0918509A1 Biocompatible devices with foam scaffolds
06/02/1999EP0918508A1 Improved masking of liposomes from res recognition
06/02/1999EP0918507A1 Aerosol formulations
06/02/1999EP0918498A1 Improved tissue injectable composition and method of use
06/02/1999EP0918458A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
06/02/1999EP0918456A1 Disintegrant composition for dispersible solids
06/02/1999EP0848607B1 Pharmaceutical compositions and devices for their administration
06/02/1999EP0767689B1 Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0740581A4 Particulate material
06/02/1999EP0726760B1 Self-emulsible formulation forming an oil-in-water emulsion
06/02/1999EP0630376B1 Condensed indole derivatives as 5-ht4-receptor antagonists
06/02/1999DE19900421A1 Viscoelastic solution for use in eye surgery
06/02/1999DE19753298A1 Verfahren zur Herstellung von festen Dosierungsformen A process for the preparation of solid dosage forms
06/02/1999DE19753297A1 Verfahren zur Herstellung von festen Dosierungsformen A process for producing solid dosage forms
06/02/1999CN1218477A Organo phosphorous compounds
06/02/1999CN1218415A Targeted hysteresis hyperthermia as method for treating diseased tissue
06/02/1999CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV
06/02/1999CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
06/02/1999CN1218398A Proopofol microdroplet formulations
06/02/1999CN1218397A Ethene containing solutions and use thereof in methods of therapy or prophylaxis
06/02/1999CN1218396A Controlled-release pharmaceutical tablet containing carried based on cross-linked amylose and hydroxypropylmethylcellulose
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1218394A Dispersible macromolecule compositions and methods for their preparation and use
06/02/1999CN1217939A Composition for health of smokers and preparing method therefor
06/02/1999CN1217938A Series of instant powder for common cold
06/02/1999CN1217937A Liuweixian ginseng tablets and preparing method therefor
06/02/1999CN1217935A Medicinal ointment for bone fracture and injury of muscle and tendon and preparing method therefor
06/02/1999CN1217929A Chinese medicine for AlDs and preparing process therefor
06/02/1999CN1217922A Visual acuity health-care paste and preparation and usage
06/02/1999CN1217921A Process for extracting purified medicinal powder of eucommia bark
06/02/1999CN1217920A Tablets for acne and preparing method therefor
06/02/1999CN1217919A Process and method for preparing paste for giving up smoking habit
06/02/1999CN1217914A Preparation and process for increasing solubility of Awei antibiotics
06/02/1999CN1043532C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
06/02/1999CN1043508C Process for preparing liquid pharmaceutical composition for controlling release treatment system
06/01/1999US5908869 Propofol compositions containing edetate
06/01/1999US5908865 Chlorhexidine gluconate-containing, stabilized aqueous pharmaceutical preparations
06/01/1999US5908853 Therapy for sexual disorders
06/01/1999US5908846 Topical compositions for transdermal delivery of prodrug derivatives of morphine
06/01/1999US5908829 Use of MCP-1 for inducing ripening of the cervix
06/01/1999US5908826 Freeze-dried preparation containing monoclonal antibody
06/01/1999US5908825 Dosage composition for nasal delivery and method of use of the same
06/01/1999US5908824 Dispersed homogeneously in and adsorbed homogeneously onto a mucosa protecting and/or tissue repairing agent
06/01/1999US5908697 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
06/01/1999US5908640 Applying a non-toxic composition of the chemical compound stannous fluoride.
06/01/1999US5908639 Inhalation powder containing antistatic agent
06/01/1999US5908638 Pharmaceutical compositions of conjugated estrogens and methods for their use
06/01/1999US5908637 Transmucosal delivery system
06/01/1999US5908636 Polyalkylene glycol having an average molecular weight of about 400 to about 20,000
06/01/1999US5908635 Method for the liposomal delivery of nucleic acids
06/01/1999US5908633 Poly-para-xylylene matrix
06/01/1999US5908628 Compositions with analgesic, antipyretic and antiinflammatory properties
06/01/1999US5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
06/01/1999US5908618 Containing neutralized polyacrylamidopropanesulfonic acid
06/01/1999US5908614 Water soluble hydrogen peroxide and ph adjustment
06/01/1999US5908611 Administering weak organic acid and pharmacological agent using inhalant or propellant
06/01/1999US5908610 Stable microbubble suspensions comprising saturated phospholipios for ultrasonic echography
06/01/1999CA2255325A1 Aldehyde oxidase inhibitors for treatment of aids
06/01/1999CA2253700A1 The production of solid dosage forms
06/01/1999CA2253695A1 The production of solid dosage forms
06/01/1999CA2144127C Antiageing and antistaining composition for skin and use thereof
06/01/1999CA2141372C Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient, maximizing its release and its use
06/01/1999CA2094266C Aerosol formulations of beclomethasone-17,21-dipropionate
06/01/1999CA2046364C Galenic process for omeprazole containing pellets
06/01/1999CA1340576C Unitary, solid and porous form containing microparticles and (or) nanoparticules, and process for preparing the same
05/1999
05/27/1999WO1999025786A1 Hydrofluorocarbon refrigerants
05/27/1999WO1999025383A1 Conjugates comprising two active agents
05/27/1999WO1999025382A1 Pharmaceutical combination of a cyclooxygenase-2 inhibitor
05/27/1999WO1999025362A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations
1 ... 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 ... 2991